Since the prostate cancer cell lines with intact androgen receptor showed higher expression levels of all tested ERAD component proteins and ERAD inhibitor of SVIP was reported as one of the novel androgen-responsive genes by sequencing of LongSAGE libraries21, we hypothesized that the ERAD pathway might be regulated by androgen. Here, SVIP is linked to prostate cancer.